Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Dabigatran
Drug ID BADD_D00563
Description Dabigatran is the active form of the orally bioavailable prodrug [dabigatran etexilate].
Indications and Usage Not Available
Marketing Status approved; investigational
ATC Code B01AE07
DrugBank ID DB14726
KEGG ID D09707
MeSH ID D000069604
PubChem ID 216210
TTD Drug ID D0M7JT
NDC Product Code 51869-0030
UNII I0VM4M70GC
Synonyms Dabigatran | N-((2-(((4-(aminoiminomethyl)phenyl)amino)methyl)-1-methyl-1H-benzimidazol-5-yl)carbonyl)-N-2-pyridinyl-beta-alanine | BIBR 1048 | Pradaxa | Dabigatran Etexilate | Etexilate, Dabigatran | Dabigatran Etexilate Mesylate | Etexilate Mesylate, Dabigatran | Mesylate, Dabigatran Etexilate
Chemical Information
Molecular Formula C25H25N7O3
CAS Registry Number 211914-51-1
SMILES CN1C2=C(C=C(C=C2)C(=O)N(CCC(=O)O)C3=CC=CC=N3)N=C1CNC4=CC=C(C=C4)C(=N)N
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Cerebral artery occlusion24.04.06.020; 17.08.01.0280.004037%Not Available
Cerebral atrophy17.11.01.0010.000367%Not Available
Cerebral haemorrhage24.07.04.001; 17.08.01.0030.059452%Not Available
Cerebral infarction24.04.06.002; 17.08.01.0040.035280%Not Available
Cerebral ischaemia17.08.01.005; 24.04.06.0030.005260%
Cerebral thrombosis24.01.04.003; 17.08.01.0060.001346%Not Available
Cerebral venous thrombosis17.08.03.002; 24.01.04.0050.000489%Not Available
Cerebrovascular accident24.03.05.001; 17.08.01.0070.212166%
Cerebrovascular disorder24.03.05.002; 17.08.02.0020.002202%Not Available
Cholangiocarcinoma09.04.02.009; 16.07.01.0020.000245%Not Available
Cholangitis09.02.01.0020.001223%Not Available
Cholecystitis09.03.01.0010.002740%
Cholecystitis acute09.03.01.0030.002814%Not Available
Circulatory collapse24.06.02.0010.002691%Not Available
Clonus17.02.05.0020.000367%Not Available
Coagulopathy01.01.02.0010.019230%Not Available
Colitis ischaemic24.04.08.012; 07.08.01.0040.002447%Not Available
Colon cancer16.13.01.001; 07.21.01.0010.007340%Not Available
Coma17.02.09.0010.006606%Not Available
Compartment syndrome24.04.05.006; 15.05.05.0050.000979%Not Available
Conjunctival haemorrhage24.07.05.001; 06.07.01.0010.001639%Not Available
Cor pulmonale22.06.01.003; 02.05.03.001; 24.08.03.0010.000245%Not Available
Coronary artery disease24.04.04.006; 02.02.01.0010.001957%Not Available
Coronary artery occlusion12.02.01.036; 24.04.04.013; 02.02.01.0060.001835%Not Available
Coronary artery stenosis12.02.01.037; 24.04.04.017; 02.02.01.0100.000612%Not Available
Coronary artery thrombosis24.01.05.002; 02.02.01.0070.000856%Not Available
Cutaneous vasculitis24.12.04.008; 23.06.02.001; 10.02.02.0030.000734%Not Available
Cystitis haemorrhagic20.03.02.0030.000367%Not Available
Decubitus ulcer23.03.11.0060.000979%Not Available
Defaecation urgency07.02.04.0010.000367%Not Available
The 3th Page    First    Pre   3 4 5 6 7    Next   Last    Total 22 Pages